AroCell TK 210 ELISA can now be used on automated platforms

AroCell TK 210 ELISA can now be used on automated platforms

Quantification of Thymidine Kinase 1 in serum with AroCell TK 210 ELISA is now validated for use on an open automation platform for ELISA. This enhances the application and use of the assay. We have now validated AroCell TK 210 ELISA for use on an automation platform,...

Redeye interview with Michael Brobjer

A new Redeye interview with Michael Brobjer, AroCell CEO, commenting interim report for the second quarter of 2020. See the interview on Redeye’s website.
AroCell Strategy day 2020

AroCell Strategy day 2020

Time: 10.00 – 12.00 CEST, June 15th 2020 On June 15, Arocell AB provides a live broadcast business update with subsequent question time led by Redeye’s analyst Oscar Bergman. CEO Michael Brobjer, together with parts of the management team, will among other...